- Home
- PBH vs CBUS Comparison
PBH vs CBUS Comparison
Compare PBH & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBH
- CBUS
- Stock Information
- Founded
- PBH 1996
- CBUS 2010
- Country
- PBH United States
- CBUS United States
- Employees
- PBH N/A
- CBUS N/A
- Industry
- PBH Biotechnology: Pharmaceutical Preparations
- CBUS Agricultural Chemicals
- Sector
- PBH Health Care
- CBUS Industrials
- Exchange
- PBH Nasdaq
- CBUS Nasdaq
- Market Cap
- PBH 3.9B
- CBUS 65.3M
- IPO Year
- PBH 2005
- CBUS 2017
- Fundamental
- Price
- PBH $76.37
- CBUS $1.54
- Analyst Decision
- PBH Buy
- CBUS Strong Buy
- Analyst Count
- PBH 5
- CBUS 3
- Target Price
- PBH $94.00
- CBUS $22.00
- AVG Volume (30 Days)
- PBH 415.9K
- CBUS 551.9K
- Earning Date
- PBH 08-07-2025
- CBUS 08-07-2025
- Dividend Yield
- PBH N/A
- CBUS N/A
- EPS Growth
- PBH 2.88
- CBUS N/A
- EPS
- PBH 4.29
- CBUS N/A
- Revenue
- PBH $1,137,762,000.00
- CBUS $4,751,000.00
- Revenue This Year
- PBH $2.04
- CBUS $32.97
- Revenue Next Year
- PBH $2.07
- CBUS $66.40
- P/E Ratio
- PBH $17.79
- CBUS N/A
- Revenue Growth
- PBH 1.10
- CBUS 104.78
- 52 Week Low
- PBH $64.94
- CBUS $1.38
- 52 Week High
- PBH $90.04
- CBUS $10.77
- Technical
- Relative Strength Index (RSI)
- PBH 23.82
- CBUS 43.03
- Support Level
- PBH $78.86
- CBUS $1.45
- Resistance Level
- PBH $80.69
- CBUS $1.65
- Average True Range (ATR)
- PBH 1.75
- CBUS 0.12
- MACD
- PBH -0.47
- CBUS 0.04
- Stochastic Oscillator
- PBH 12.38
- CBUS 55.17
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.